Cargando…
Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620580/ https://www.ncbi.nlm.nih.gov/pubmed/34829455 http://dx.doi.org/10.3390/diagnostics11112107 |
_version_ | 1784605253828608000 |
---|---|
author | Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Popp, Radu Anghel Pascanu, Ionela Maria Cret, Victoria Ghervan, Cristina Blaga, Ligia Zaharie, Gabriela |
author_facet | Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Popp, Radu Anghel Pascanu, Ionela Maria Cret, Victoria Ghervan, Cristina Blaga, Ligia Zaharie, Gabriela |
author_sort | Miclea, Diana |
collection | PubMed |
description | Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical Emergency Hospital for Children Cluj-Napoca between January 2012 and December 2019. Each patient was clinically, biochemically, and morphologically evaluated. As a first intervention, the genetic test included karyotype + SRY testing. A high value of 17-hydroxyprogesterone was found in 39 patients, in whom strip assay analysis of the CYP21A2 gene was subsequently performed. A total of 35 patients were evaluated by chromosomal microarray technique, and 22 patients were evaluated by the NGS of a gene panel. Results. The karyotype analysis established the diagnosis in 15% of the patients, most of whom presented with sex chromosome abnormalities. Genetic testing of CYP21A2 established a confirmation of the diagnosis in 44% of patients tested. SNP array analysis was particularly useful in patients with syndromic DSD; 20% of patients tested presented with pathogenic CNVs or uniparental disomy. Gene panel sequencing established the diagnosis in 11 of the 22 tested patients (50%), and the androgen receptor gene was most often involved in these patients. The genes that presented as pathogenic or likely pathogenic variants or variants of uncertain significance were RSPO1, FGFR1, WT1, CHD7, AR, NIPBL, AMHR2, AR, EMX2, CYP17A1, NR0B1, GNRHR, GATA4, and ATM genes. Conclusion. An evaluation following a genetic testing protocol that included karyotype and SRY gene testing, CYP21A2 analysis, chromosomal analysis by microarray, and high-throughput sequencing were useful in establishing the diagnosis, with a spectrum of diagnostic yield depending on the technique (between 15 and 50%). Additionally, new genetic variants not previously described in DSD were observed. |
format | Online Article Text |
id | pubmed-8620580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86205802021-11-27 Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Popp, Radu Anghel Pascanu, Ionela Maria Cret, Victoria Ghervan, Cristina Blaga, Ligia Zaharie, Gabriela Diagnostics (Basel) Article Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical Emergency Hospital for Children Cluj-Napoca between January 2012 and December 2019. Each patient was clinically, biochemically, and morphologically evaluated. As a first intervention, the genetic test included karyotype + SRY testing. A high value of 17-hydroxyprogesterone was found in 39 patients, in whom strip assay analysis of the CYP21A2 gene was subsequently performed. A total of 35 patients were evaluated by chromosomal microarray technique, and 22 patients were evaluated by the NGS of a gene panel. Results. The karyotype analysis established the diagnosis in 15% of the patients, most of whom presented with sex chromosome abnormalities. Genetic testing of CYP21A2 established a confirmation of the diagnosis in 44% of patients tested. SNP array analysis was particularly useful in patients with syndromic DSD; 20% of patients tested presented with pathogenic CNVs or uniparental disomy. Gene panel sequencing established the diagnosis in 11 of the 22 tested patients (50%), and the androgen receptor gene was most often involved in these patients. The genes that presented as pathogenic or likely pathogenic variants or variants of uncertain significance were RSPO1, FGFR1, WT1, CHD7, AR, NIPBL, AMHR2, AR, EMX2, CYP17A1, NR0B1, GNRHR, GATA4, and ATM genes. Conclusion. An evaluation following a genetic testing protocol that included karyotype and SRY gene testing, CYP21A2 analysis, chromosomal analysis by microarray, and high-throughput sequencing were useful in establishing the diagnosis, with a spectrum of diagnostic yield depending on the technique (between 15 and 50%). Additionally, new genetic variants not previously described in DSD were observed. MDPI 2021-11-14 /pmc/articles/PMC8620580/ /pubmed/34829455 http://dx.doi.org/10.3390/diagnostics11112107 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Popp, Radu Anghel Pascanu, Ionela Maria Cret, Victoria Ghervan, Cristina Blaga, Ligia Zaharie, Gabriela Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title | Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title_full | Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title_fullStr | Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title_full_unstemmed | Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title_short | Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development |
title_sort | molecular and cytogenetic analysis of romanian patients with differences in sex development |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620580/ https://www.ncbi.nlm.nih.gov/pubmed/34829455 http://dx.doi.org/10.3390/diagnostics11112107 |
work_keys_str_mv | AT micleadiana molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT alkhzouzcamelia molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT bucerzansimona molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT grigorescusidopaula molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT poppraduanghel molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT pascanuionelamaria molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT cretvictoria molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT ghervancristina molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT blagaligia molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment AT zahariegabriela molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment |